Cargando…
Safranal Inhibits Angiogenesis via Targeting HIF-1α/VEGF Machinery: In Vitro and Ex Vivo Insights
Nature has a nearly infinite inventory of unexplored phytochemicals and biomolecules that have the potential to treat a variety of diseases. Safranal exhibits anti-cancer property and the present study explores its antiangiogenic property. Hepatocellular carcinoma (HCC) ranks as the sixth deadliest...
Autores principales: | Abdalla, Ali, Murali, Chandraprabha, Amin, Amr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862147/ https://www.ncbi.nlm.nih.gov/pubmed/35211395 http://dx.doi.org/10.3389/fonc.2021.789172 |
Ejemplares similares
-
Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation
por: Abdalla, Youssef, et al.
Publicado: (2022) -
Safranal induces DNA double-strand breakage and ER-stress-mediated cell death in hepatocellular carcinoma cells
por: Al-Hrout, Ala’a, et al.
Publicado: (2018) -
Houshiheisan promotes angiogenesis via HIF-1α/VEGF and SDF-1/CXCR4 pathways: in vivo and in vitro
por: Xiang, Yangyang, et al.
Publicado: (2019) -
Regulation of Osteogenesis-Angiogenesis Coupling by HIFs and VEGF
por: Schipani, Ernestina, et al.
Publicado: (2009) -
Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM)
por: Yang, Xiaobing, et al.
Publicado: (2023)